Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV/EBITDA
-4.58 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Progenics Pharmaceuticals Inc's enterprise value is $203.46 Mil. Progenics Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2015 was $-44.43 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/EBITDA ratio for today is -4.58.

During the past 13 years, the highest EV/EBITDA Ratio of Progenics Pharmaceuticals Inc was 233.20. The lowest was -132.80. And the median was -4.65.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Progenics Pharmaceuticals Inc's stock price is $4.21. Progenics Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.64. Therefore, Progenics Pharmaceuticals Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Progenics Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=203.461/-44.428
=-4.58

Progenics Pharmaceuticals Inc's current Enterprise Value is $203.46 Mil.
Progenics Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2015 was -12.828 (Dec. 2014 ) + -10.134 (Mar. 2015 ) + -11.579 (Jun. 2015 ) + -9.887 (Sep. 2015 ) = $-44.43 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Progenics Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=4.21/-0.635
=

Progenics Pharmaceuticals Inc's share price for today is $4.21.
Progenics Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2015 was -0.175 (Dec. 2014 ) + -0.15 (Mar. 2015 ) + -0.17 (Jun. 2015 ) + -0.14 (Sep. 2015 ) = $-0.64.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -6.88-19.78-8.47-4.34-1.81-1.9817.68-2.34-6.15103.98

Progenics Pharmaceuticals Inc Quarterly Data

Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15
ev2ebitda -5.47-6.89-6.15-4.62-5.4734.26103.98103.99179.87-6.95
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK